News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400     7/9/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Exciting Time for Biotech in New Jersey     6/29/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS     5/12/2015
Gilead (GILD)'s Next-Gen HIV Drug Heads to the FDA, Stock Soars     4/10/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     3/2/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It?     2/23/2015
TRICON: Chimerix (CMRX): Antivirals Are Undergoing a Renaissance, As Infectious Disease Comes Front and Center     2/18/2015
FDA Green Lights Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ) HIV Pills     1/30/2015

News from Around the Web
Vaginal Microbes Species Traps HIV, May Be A Biological Condom Someday, University of North Carolina Study     10/8/2015
WHO Ramps Up HIV Drug Push With Call For Early Treatment For All     9/30/2015
Silicone Vaginal Rings To Deliver Antiviral Drugs, Protect Women Against HIV, University Jean Monnet Of Saint-Etienne Study     9/22/2015
International Team Discovers Natural Defense Against HIV, Michigan State University Study     9/16/2015
Encouraging Results From Real-World Users Of Gilead (GILD)'s HIV-Prevention Pill Truvada     9/14/2015
2-Pound DNA-Reader Could Help Fight Ebola, TB, HIV     7/30/2015
Teen's HIV In Remission Despite Stopping Treatment As A Child, Pasteur Institute Reveals     7/21/2015
$4 Million Boost To Turn The Tide On AIDS In Cuyahoga County     7/7/2015
Cuba Becomes First To Eliminate Mother-To-Child HIV     7/1/2015
Vitamin D May Help Fight HIV, Penn State University Study     6/19/2015
Dirty Needles Spread HIV In Indiana As Pain Pills Injected     3/30/2015
Give HIV Drugs To Healthy Gay Men, UK Medical Research Council (MRC) Reveals     2/25/2015
Bill Gates Predicts An HIV Vaccine By 2030     1/30/2015
Birth Control Shot Linked To Increased HIV Risk, University of California, Berkeley (CAL) Study     1/12/2015
The Reason Why Experimental HIV Vaccines Backfire, Emory University Study Suggests     1/7/2015

Press Releases
ABIVAX - 2015 Half-Year Results €57.7 Million Raised On Euronext And Significant Clinical Progress On Chronic Hepatitis B And HIV/AIDS     9/29/2015
Alere (ALR) Expands Commitment To Support Organisation Of African First Ladies Against HIV/AIDS (OAFLA) In Efforts To Reduce Mother-To-Child Transmission Of HIV And Syphilis And Enhance HIV Early Infant Diagnosis     9/28/2015
European CHMP Adopts Positive Opinion For Gilead (GILD)’s Single Tablet Regimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide) For The Treatment Of HIV     9/25/2015
Arno Therapeutics To Present Late-Breaking Abstract On AR-12 As Novel Therapeutic Candidate Against HIV Multidrug Resistant Strains At 15th European AIDS Conference     9/25/2015
ViiV Healthcare Release: New Phase IIIb/IV Data Show Switching To Once-Daily Triumeq Maintains HIV Viral Suppression     9/23/2015
Mologen AG (MOLGF.PK): Recruitment For The TEACH Study With MGN1703 In HIV-Patients Completed     9/22/2015
CytoDyn Release: HIV Patients Successfully Reach One Year Of Virologic Suppression In PRO 140 Monotherapy Study     9/21/2015
Sedia Biosciences Expands Its HIV-1 Lag-Avidity Assay For Recent HIV-1 Infections To Dried Blood Spot Specimens     9/21/2015
IAVI And CureVac Partner To Accelerate Development And Testing Of AIDS Vaccine Candidates     9/9/2015
Inovio Pharma (INO) Announces First Patient Dosed With Universal HIV Vaccine     9/8/2015
Mylan (MYL) Launches Generic Yasmin Tablets     9/8/2015
bioLytical™ Laboratories's INSTI HIV Test Detects gp41 Specific IgM Antibodies     9/3/2015
Gilead (GILD)’s Investigational Fixed-Dose Combination Of Emtricitabine/Tenofovir Alafenamide (F/TAF) Meets Primary 48-Week Objective In Phase III Study     9/2/2015
BioTime (BTX) Chief Executive Officer Dr. Michael D. West To Be Keynote Speaker At Stem Cells & Regenerative Medicine Congress 2015     9/1/2015
Argos Therapeutics, Inc. (ARGS) Awarded Patent For Its Experimental Individualized Immunotherapy For The Treatment Of HIV Infection     8/24/2015